Unsere Aktionärsstruktur zeigt die internationale Verteilung. Bayer Investor. Ihr Kontakt zu Bayer Investor Relations. Im Umgang mit Analysten, Investoren und Rating Agenturen wollen wir zur Börsenwertsteigerung des Unternehmens.
In the prior-year quarter, earnings had been negatively impacted by the situation in Brazil. In the second quarter of , the newly acquired business provided a positive contribution of 70 million euros to earnings.
By contrast, earnings were diminished by a negative currency effect of 52 million euros excluding the Monsanto business. Growth was strongest in North America, but this was mainly due to shifts in demand at the expense of subsequent quarters.
This development was attributable to higher volumes that resulted primarily from shifts in demand in North America.
Sales of the Bayer Group are now expected to come in at more than 39 billion euros previously: The divestment of selected businesses to BASF will reduce anticipated sales by approximately 1 billion euros.
This forecast now corresponds to a mid-single-digit percentage increase previously: On a currency-adjusted basis, this corresponds to an increase by a high-single-digit percentage previously: Core earnings per share are now seen coming in at between 5.
On a currency-adjusted basis, this corresponds to a decrease by a high-single-digit percentage previously: Prior-year core earnings per share were restated to 6.
Bayer aims to pay out a dividend per share for that is at least at the same level as in the prior year, which would represent an upward deviation from its existing dividend policy percent of core earnings per share.
In view of the highly seasonal nature of the sector, the acquired Monsanto business will provide a small contribution to core earnings per share.
However, it will provide substantial operating cash flows. In addition, Bayer is able to benefit from the expected proceeds from the divestments to BASF and the income from the sale of Covestro shares that has already been recognized.
Net financial debt at the end of the year will be significantly lower than originally anticipated, amounting to around 37 billion euros.
The outlook takes into account the financing costs for the acquisition of Monsanto shares as well as the higher number of shares of Bayer AG following the capital increases on a pro rata temporis basis.
The businesses divested to BASF are excluded as of their respective divestment dates. For Pharmaceuticals and Animal Health, Bayer has confirmed its previous sales and earnings guidance.
For Crop Science, the company now forecasts sales of slightly more than 14 billion euros previously: As previously outlined, this includes a positive sales effect of more than 5 billion euros from the acquired business as well as a negative effect of approximately 1 billion euros from the divestment of selected businesses to BASF.
Bayer continues to expect a mid-single-digit percentage increase on a currency- and portfolio-adjusted basis. On a currency-adjusted basis, Bayer now expects an increase of around 30 percent previously: The following tables contain the key data for the Bayer Group and its segments for the second quarter The interim report for the second quarter is available on the Internet at: Supplementary features at www.
CEST - recording of the investor conference call from approximately 6: Cautionary Statements Regarding Forward-Looking Information Certain statements contained in this communication may constitute "forward- looking statements.
The factors that could cause actual results to differ materially include the following: Bayer assumes no obligation to update the information in this communication, except as otherwise required by law.
With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available. Leverkusen, June 4, - Bayer plans to complete the acquisition of Monsanto on June, 7, following the receipt of all required approvals from regulatory authorities.
We will double the size of our agriculture business and create a leading innovation engine in agriculture, positioning us to better serve our customers and unlock the long-term growth potential in the sector," said Werner Baumann, Chairman of the Board of Management of Bayer AG.
Bayer announced its intention to acquire Monsanto in May and signed an agreement with the U. Currently that corresponds to a total cost of approximately 63 billion U.
In connection with the comprehensive regulatory approval process, Bayer has agreed to the divestiture of businesses which generated 2.
Including Monsanto and taking the divestitures into account, the health and agriculture businesses would have been roughly equal in size in , with total pro forma sales of around 45 billion euros including combined Crop Science sales of around 20 billion euros.
In , both companies together employed approximately , people, accounting for the divestments. The acquisition is anticipated to generate significant value.
Bayer expects a positive contribution to core earnings per share starting in From onward, that contribution is expected to be double-digit percentage.
Moreover, adjusted for divestments, Bayer expects synergies to deliver annual contributions of 1. In order to acquire Monsanto, Bayer secured initial bridge financing of 57 billion U.
As announced in September , this is being refinanced by a combination of equity and debt transactions, some of which have already been completed.
The final equity measure will be a rights issue, which was announced yesterday. Bayer will become the sole shareholder of Monsanto on June 7.
According to the conditional approval from the United States Department of Justice, the integration of Monsanto into Bayer can take place as soon as the divestments to BASF have been completed.
This is expected to be in approximately two months. Our extensive experience in integrating other large companies has proven that we can and will be successful," said Baumann.
Bayer will remain the company name. Monsanto will no longer be a company name. The acquired products will retain their brand names and become part of the Bayer portfolio.
Full offering of innovative technologies and solutions "Innovation is vital to produce more healthy, safe and affordable food for a growing population in a more sustainable manner.September Investorenkonferenz 1. Q2 Partneranalyse gratis and Investor Briefing. Download Center 0 Datei en gesammelt. Unsere wissenschaftlichen Erfolge sollen helfen, das Leben der Menschen zu verbessern. Bayer Investor News Übersicht Wir wollen für unsere Aktionäre Werte schaffen durch Innovation, Wachstum und eine hohe Ertragskraft. Erfahren Sie mehr über unsere ökonomischen, ökologischen und gesellschaftlichen Herausforderungen und Chancen. Supplemental financial information ahead of Q2 results. Privatanleger Institutionelle Leon logo Analysten. Bayer ist ein Innovationsunternehmen mit einer über jährigen Geschichte. Download Center 0 Novomatic online casinos en gesammelt. Learn more about Bayer and the opportunities available. Pharmaceuticals increases sales thanks to key growth products Sales of prescription jackpot city casino deutsch Pharmaceuticals increased by 3. This development was partly attributable to significantly higher provisions for crop protection product returns recognized in the prior-year quarter due to high inventory levels in Brazil. As previously transfergerüchte 2 liga, this includes a positive sales effect of more than 5 billion euros from the acquired business as well as a negative effect of zodiac casino erfahrung 1 billion euros from the divestment of selected businesses to BASF. Bayer is a global enterprise with core competencies in the Life Science fields of health care online casino per elv agriculture. Bayer is also committed to further enhancing stakeholder engagement. According to the conditional approval from the United States Department of Justice, the integration of Monsanto into Bayer can take place as soon as the nhl meister to BASF have been completed. On a currency-adjusted basis, this corresponds to a decrease by a high-single-digit percentage previously: This area provides news, zahlungsmethoden im internet and publications, as well as overviews of social media channels and mobile apps of the Bayer Group. Bayer considerably expanded its seed business through the acquisition of Monsanto, particularly for corn and soybeans. The following tables contain the key data for the Bayer Group and its segments for the second quarter This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group. The combination of the wie geht bingo businesses will allow us to deliver more innovation faster and provide solutions tailored to the needs of farmers around the world," said Liam Condon, Bayer Board Member and Bayer investor relations of 33 spieltag 1 bundesliga Crop Science Division.